Impact of Delta SARS-CoV-2 Infection on Glucose Metabolism : Insights on Host Metabolism and Virus Crosstalk in a Feline Model
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) causes enhanced mortality in people with metabolic and cardiovascular diseases. Other highly infectious RNA viruses have demonstrated dependence on glucose transport and utilization, so we hypothesized that SARS-CoV-2 infection could lead to alterations in cellular and whole-body glucose metabolism. Twenty-four healthy domestic cats were intratracheally inoculated with B.1.617.2 (delta) SARS-CoV-2 and samples were collected at 4- and 12-days post-inoculation (dpi). Blood glucose and circulating cortisol concentrations were elevated at 4 and 12 dpi. Serum insulin concentration was statistically significantly decreased, while angiotensin 2 concentration was elevated at 12 dpi. SARS-CoV-2 RNA was detected in the pancreas and skeletal muscle at low levels; however, no change in the number of insulin-producing cells or proinflammatory cytokines was observed in the pancreas of infected cats through 12 dpi. SARS-CoV-2 infection statistically significantly increased GLUT protein expression in both the heart and lungs, correlating with increased AMPK expression. In brief, SARS-CoV-2 increased blood glucose concentration and cardio-pulmonary GLUT expression through an AMPK-dependent mechanism, without affecting the pancreas, suggesting that SARS-CoV-2 induces the reprogramming of host glucose metabolism. A better understanding of host cell metabolism and virus crosstalk could lead to the discovery of novel metabolic therapeutic targets for patients affected by COVID-19.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
---|---|
Enthalten in: |
Viruses - 16(2024), 2 vom: 15. Feb. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Rochowski, Matthew T [VerfasserIn] |
---|
Links: |
---|
Themen: |
AMP-Activated Protein Kinases |
---|
Anmerkungen: |
Date Completed 26.02.2024 Date Revised 27.02.2024 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.3390/v16020295 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM368900495 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM368900495 | ||
003 | DE-627 | ||
005 | 20240229164810.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240229s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/v16020295 |2 doi | |
028 | 5 | 2 | |a pubmed24n1309.xml |
035 | |a (DE-627)NLM368900495 | ||
035 | |a (NLM)38400070 | ||
035 | |a (PII)295 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Rochowski, Matthew T |e verfasserin |4 aut | |
245 | 1 | 0 | |a Impact of Delta SARS-CoV-2 Infection on Glucose Metabolism |b Insights on Host Metabolism and Virus Crosstalk in a Feline Model |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 26.02.2024 | ||
500 | |a Date Revised 27.02.2024 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) causes enhanced mortality in people with metabolic and cardiovascular diseases. Other highly infectious RNA viruses have demonstrated dependence on glucose transport and utilization, so we hypothesized that SARS-CoV-2 infection could lead to alterations in cellular and whole-body glucose metabolism. Twenty-four healthy domestic cats were intratracheally inoculated with B.1.617.2 (delta) SARS-CoV-2 and samples were collected at 4- and 12-days post-inoculation (dpi). Blood glucose and circulating cortisol concentrations were elevated at 4 and 12 dpi. Serum insulin concentration was statistically significantly decreased, while angiotensin 2 concentration was elevated at 12 dpi. SARS-CoV-2 RNA was detected in the pancreas and skeletal muscle at low levels; however, no change in the number of insulin-producing cells or proinflammatory cytokines was observed in the pancreas of infected cats through 12 dpi. SARS-CoV-2 infection statistically significantly increased GLUT protein expression in both the heart and lungs, correlating with increased AMPK expression. In brief, SARS-CoV-2 increased blood glucose concentration and cardio-pulmonary GLUT expression through an AMPK-dependent mechanism, without affecting the pancreas, suggesting that SARS-CoV-2 induces the reprogramming of host glucose metabolism. A better understanding of host cell metabolism and virus crosstalk could lead to the discovery of novel metabolic therapeutic targets for patients affected by COVID-19 | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a AMPK | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a GLUT | |
650 | 4 | |a angiotensin 2 | |
650 | 4 | |a cortisol | |
650 | 4 | |a insulin | |
650 | 7 | |a RNA, Viral |2 NLM | |
650 | 7 | |a Blood Glucose |2 NLM | |
650 | 7 | |a AMP-Activated Protein Kinases |2 NLM | |
650 | 7 | |a EC 2.7.11.31 |2 NLM | |
650 | 7 | |a Insulins |2 NLM | |
700 | 1 | |a Jayathilake, Kaushalya |e verfasserin |4 aut | |
700 | 1 | |a Balcerak, John-Michael |e verfasserin |4 aut | |
700 | 1 | |a Selvan, Miruthula Tamil |e verfasserin |4 aut | |
700 | 1 | |a Gunasekara, Sachithra |e verfasserin |4 aut | |
700 | 1 | |a Miller, Craig |e verfasserin |4 aut | |
700 | 1 | |a Rudd, Jennifer M |e verfasserin |4 aut | |
700 | 1 | |a Lacombe, Véronique A |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Viruses |d 2009 |g 16(2024), 2 vom: 15. Feb. |w (DE-627)NLM192382764 |x 1999-4915 |7 nnns |
773 | 1 | 8 | |g volume:16 |g year:2024 |g number:2 |g day:15 |g month:02 |
856 | 4 | 0 | |u http://dx.doi.org/10.3390/v16020295 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 16 |j 2024 |e 2 |b 15 |c 02 |